Vanderbilt researchers have identified a new vulnerability in lung cancer — the transporter protein xCT — that may a therapeutic target for the disease.

A receptor previously implicated in asthma may also play roles in other allergic diseases and in leukemia, Vanderbilt researchers have discovered.

An international team of researchers has integrated gene expression and disease association data to better understand the biological mechanisms of complex human diseases.

One out of five deaths within 30 days of surgery are associated with a complication, suggesting that prevention and better treatment of common complications will improve postoperative mortality rates.

New findings open opportunities to understand mechanisms of DNA repair for a toxic form of DNA damage.

A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.